The Pharmaceutical Market: USA
News | 29 May 2012
Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
Click on the link to read the full article at MarketWatch (press release)
(This link will open in a new window)
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
